Trinity Biotech plc (NASDAQ: TRIB) Stock Information | RedChip
Trinity Biotech plc NASDAQ: TRIB logo small-cap
NASDAQ: TRIB

Trinity Biotech plc

$3.13 -0.1600 -4.86% 151.3K

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.

Sign Up For TRIB Email News Alerts

First Name*
Last Name*
Phone*
Email*

*By entering your information you agree to our privacy policy.